BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Acambis PLC Restructures Organization to Focus Resources on Key Programs and Operations, and Reduce Cost Base by 20%

  April 18, 2007

   · 

  1 min read
• Business

  Abbott Laboratories (Jobs) Profit Falls; Shares Slip on Humira Concern

  April 18, 2007

   · 

  18 min read
• BioCapital

  Shelhigh, Inc. Seizes All Medical Products From N.J. Device Manufacturer, Shelhigh, Inc. for Significant Manufacturing Violations

  April 18, 2007

   · 

  1 min read
• Biotech Bay

  Alexza Pharmaceuticals, Inc. Announces Public Offering of Common Stock

  April 18, 2007

   · 

  3 min read
• Drug Development

  Pre-Clinical Study Using Martek Biosciences Corporation’s DHA Reduces Brain Lesions in Alzheimer’s Animal Model

  April 18, 2007

   · 

  4 min read
• Drug Development

  Favrille, Inc. Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma

  April 18, 2007

   · 

  4 min read
• Drug Development

  Avalon Pharmaceuticals AVN944 Shows Potent Antiproliferative Activity in Human Endothelial Cells

  April 18, 2007

   · 

  5 min read
• BioCapital

  CEL-SCI Announces $15 Million Financing

  April 18, 2007

   · 

  2 min read
• Drug Development

  Data Presented at American Association for Cancer Research Meeting Show Peregrine Pharmaceuticals, Inc.'s Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer

  April 18, 2007

   · 

  7 min read
• FDA

  Ajinomoto and Takeda Pharmaceutical Co. Ltd. Release: A Once-weekly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent, Was Approved in Japan

  April 18, 2007

   · 

  1 min read